Clifford Swan Investment Counsel’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,096
| Closed | -$293K | – | 314 |
|
|
2019
Q2 | $293K | Sell |
7,096
-1,750
| -20% | -$72.3K | 0.02% | 260 |
|
|
2019
Q1 | $358K | Sell |
8,846
-3,183
| -26% | -$129K | 0.02% | 234 |
|
|
2018
Q4 | $457K | Sell |
12,029
-429
| -3% | -$16.3K | 0.03% | 207 |
|
|
2018
Q3 | $493K | Sell |
12,458
-4,952
| -28% | -$196K | 0.03% | 208 |
|
|
2018
Q2 | $611K | Hold |
17,410
| – | – | 0.03% | 190 |
|
|
2018
Q1 | $609K | Hold |
17,410
| – | – | 0.03% | 192 |
|
|
2017
Q4 | $604K | Hold |
17,410
| – | – | 0.03% | 199 |
|
|
2017
Q3 | $590K | Hold |
17,410
| – | – | 0.04% | 197 |
|
|
2017
Q2 | $594K | Sell |
17,410
-1,270
| -7% | -$43.3K | 0.04% | 204 |
|
|
2017
Q1 | $582K | Hold |
18,680
| – | – | 0.04% | 197 |
|
|
2016
Q4 | $510K | Sell |
18,680
-245
| -1% | -$6.69K | 0.03% | 195 |
|
|
2016
Q3 | $622K | Buy |
18,925
+8,925
| +89% | +$293K | 0.04% | 178 |
|
|
2016
Q2 | $302K | Hold |
10,000
| – | – | 0.02% | 219 |
|
|
2016
Q1 | $282K | Hold |
10,000
| – | – | 0.02% | 229 |
|
|
2015
Q4 | $340K | Hold |
10,000
| – | – | 0.02% | 219 |
|
|
2015
Q3 | $318K | Hold |
10,000
| – | – | 0.02% | 216 |
|
|
2015
Q2 | $319K | Hold |
10,000
| – | – | 0.02% | 214 |
|
|
2015
Q1 | $342K | Hold |
10,000
| – | – | 0.02% | 209 |
|
|
2014
Q4 | $352K | Hold |
10,000
| – | – | 0.02% | 206 |
|
|
2014
Q3 | $357K | Hold |
10,000
| – | – | 0.02% | 202 |
|
|
2014
Q2 | $372K | Hold |
10,000
| – | – | 0.03% | 201 |
|
|
2014
Q1 | $324K | Hold |
10,000
| – | – | 0.02% | 207 |
|
|
2013
Q4 | $297K | Buy |
10,000
+2,000
| +25% | +$59.4K | 0.02% | 202 |
|
|
2013
Q3 | $208K | Buy |
+8,000
| New | +$208K | 0.02% | 216 |
|